Quantitative radiowater [15O] H2O PET myocardial perfusion imaging in patients receiving Enhanced External Counter Pulsation (EECP) therapy : Pilot study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20210920004

Enrollment

Registered

2021-09-20

Start date

2020-07-13

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary artery disease patients who has contraindication for revascularization and will receive EECP. coronary artery disease EECP radiowater PET

Interventions

Patients with coronary artery disease who will perform EECP.

Diagnostic

EECP

Eligibility

Sex/Gender

All

Age

30 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age 30-80 2. Evidence of coronary artery disease 3. Abnormal stress-induced myocardial perfusion imaging 4. Patient with contraindication for revascularization 5. Clinical symptom of coronary artery disease at least 3 months 6. Patient has willing to perform EECP

Exclusion criteria

Exclusion criteria: 1. Pregnancy or breast feeding 2 Clinical chest pain from other condition 3. Valvular heart disease or cardiac congenital abnormality 4. Heart failure 5. Atrial fibrillation, 2nd or 3rd degree AV block 6. Symptom of asthma or COPD

Design outcomes

Primary

Measure	Time frame
Difference of hyperemic myocardial blood flow after EECP PET MPI,Difference of coronary flow reserve after EECP PET MPI	—

Secondary

Measure	Time frame
Major cardiac event 2 year after EECP Medical record	—

Countries

Thailand

Contacts

Public ContactChanisa Chotipanich

National Cyclotron and PET Centre, Chulabhorn Hospital

ncpc.cyclo2m@gmail.com0960918369

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026